Yes, other companies are developing oral versions of GLP-1 and dual-acting drugs, though most are still in clinical trials
One would think that with all the off-label use of various substances in the bodybuilding circles over decades, the practice of using the minimal effective dose for every substance would have become common...apparently not
Semaglutide has also shown potential benefits for cardiovascular health, lowering the risk of major cardiovascular events in patients with type 2 diabetes
BMI of 30 or higher (obesity) BMI of 27 or higher with at least one weight-related condition (hypertension, high cholesterol, sleep apnea, Type 2 diabetes, or cardiovascular disease) Prior difficulty maintaining weight loss through diet and exercise alone No contraindicated medical history (reviewed at consultation) Commitment to regular monitoring and follow-up visits Personal or family history of medullary thyroid carcinoma (MTC) Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Prior serious hypersensitivity reaction to semaglutide or excipients Current pregnancy or active breastfeeding Certain pancreatic conditions (evaluated at consultation) Not sure if you qualify
The refrigerator, specifically the main compartment where temperatures are most stable